Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

440 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Non-serious adverse events in patients with ulcerative colitis receiving etrasimod: an analysis of the phase II OASIS and phase III ELEVATE UC 52 and ELEVATE UC 12 clinical trials.
Lees CW, Torres J, Leung Y, Vermeire S, Fellmann M, Modesto I, McDonnell A, Lazin K, Keating M, Goetsch M, Wu J, Loftus EV Jr. Lees CW, et al. Among authors: loftus ev jr. Therap Adv Gastroenterol. 2024 Nov 7;17:17562848241293643. doi: 10.1177/17562848241293643. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 39526078 Free PMC article.
The Future of Inflammatory Bowel Disease Care.
Loftus EV Jr, Torres J, Hou JK, Kahi C, Singh S. Loftus EV Jr, et al. Clin Gastroenterol Hepatol. 2024 Oct 24:S1542-3565(24)00946-7. doi: 10.1016/j.cgh.2024.10.004. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 39454983 No abstract available.
Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Ulcerative Colitis: 2024 American Gastroenterological Association Evidence Synthesis.
Ananthakrishnan AN, Murad MH, Scott FI, Agrawal M, Haydek JP, Limketkai BN, Loftus EV Jr, Singh S. Ananthakrishnan AN, et al. Among authors: loftus ev jr. Gastroenterology. 2024 Dec;167(7):1460-1482. doi: 10.1053/j.gastro.2024.07.046. Epub 2024 Oct 18. Gastroenterology. 2024. PMID: 39425738
Characteristics, clinical outcomes, and prognostic factors of colorectal cancer in patients with Crohn's disease: American versus Korean tertiary referral center perspectives.
Suttichaimongkol T, Hwang SW, Coelho-Prabhu N, Kisiel JB, Ye BD, Yang SK, Loftus EV Jr, Park SH. Suttichaimongkol T, et al. Among authors: loftus ev jr. Therap Adv Gastroenterol. 2024 Sep 18;17:17562848241275342. doi: 10.1177/17562848241275342. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 39314760 Free PMC article.
Induction of Endoscopic Response, Remission, and Ulcer-Free Endoscopy With Upadacitinib Is Associated With Improved Clinical Outcomes and Quality of Life in Patients With Crohn's Disease.
Panés J, Louis E, Bossuyt P, Joshi N, Lee WJ, Lacerda AP, Kligys K, Xuan S, Shukla N, Loftus EV Jr. Panés J, et al. Among authors: loftus ev jr. Inflamm Bowel Dis. 2024 Sep 4:izae200. doi: 10.1093/ibd/izae200. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 39231444
Long-term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow-up in the SELECTION open-label long-term extension study.
Feagan BG, Matsuoka K, Rogler G, Laharie D, Vermeire S, Danese S, Loftus EV Jr, Beales I, Schreiber S, Kim HJ, Faes M, de Haas A, Masior T, Rudolph C, Peyrin-Biroulet L. Feagan BG, et al. Among authors: loftus ev jr. Aliment Pharmacol Ther. 2024 Sep;60(5):563-584. doi: 10.1111/apt.18158. Epub 2024 Jul 31. Aliment Pharmacol Ther. 2024. PMID: 39086130 Clinical Trial.
440 results